Publication | Closed Access
P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma
34
Citations
0
References
2015
Year
MedicineMelanomaImmunologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologySkin Cancer
No additional data available for this publication yet. Check back later!